Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
BMC Pulm Med ; 24(1): 213, 2024 May 02.
Article in English | MEDLINE | ID: mdl-38698403

ABSTRACT

INTRODUCTION: Ventilator-associated pneumonia (VAP) presents a significant challenge in intensive care units (ICUs). Nebulized antibiotics, particularly colistin and tobramycin, are commonly prescribed for VAP patients. However, the appropriateness of using inhaled antibiotics for VAP remains a subject of debate among experts. This study aims to provide updated insights on the efficacy of adjunctive inhaled colistin and tobramycin through a comprehensive systematic review and meta-analysis. METHODS: A thorough search was conducted in MEDLINE, EMBASE, LILACS, COCHRANE Central, and clinical trials databases ( www. CLINICALTRIALS: gov ) from inception to June 2023. Randomized controlled trials (RCTs) meeting specific inclusion criteria were selected for analysis. These criteria included mechanically ventilated patients diagnosed with VAP, intervention with inhaled Colistin and Tobramycin compared to intravenous antibiotics, and reported outcomes such as clinical cure, microbiological eradication, mortality, or adverse events. RESULTS: The initial search yielded 106 records, from which only seven RCTs fulfilled the predefined inclusion criteria. The meta-analysis revealed a higher likelihood of achieving both clinical and microbiological cure in the groups receiving tobramycin or colistin compared to the control group. The relative risk (RR) for clinical cure was 1.23 (95% CI: 1.04, 1.45), and for microbiological cure, it was 1.64 (95% CI: 1.31, 2.06). However, there were no significant differences in mortality or the probability of adverse events between the groups. CONCLUSION: Adjunctive inhaled tobramycin or colistin may have a positive impact on the clinical and microbiological cure rates of VAP. However, the overall quality of evidence is low, indicating a high level of uncertainty. These findings underscore the need for further rigorous and well-designed studies to enhance the quality of evidence and provide more robust guidance for clinical decision-making in the management of VAP.


Subject(s)
Anti-Bacterial Agents , Colistin , Pneumonia, Ventilator-Associated , Tobramycin , Humans , Pneumonia, Ventilator-Associated/drug therapy , Tobramycin/administration & dosage , Colistin/administration & dosage , Administration, Inhalation , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Randomized Controlled Trials as Topic , Intensive Care Units , Treatment Outcome , Respiration, Artificial
3.
Pediatr Pulmonol ; 2024 Apr 25.
Article in English | MEDLINE | ID: mdl-38661231

ABSTRACT

INTRODUCTION: Predicting response to inhaled corticosteroids (ICSs) + long-acting ß2-agonist (LABA) by previously detecting the presence of Arg16Gly ADRB2 genotype is a strategy that could reduce and optimize the management of asthmatic patients. There is a need for economic evaluations to facilitate the implementation of such tests. This research aims to evaluate the cost-effectiveness of Arg16Gly ADRB2 screening in children with asthma in Colombia. METHODS: From the perspective of a third-party payer, we conducted a cost-effectiveness analysis to determine the cost and quality-adjusted life-years (QALYs) of genotype-driven asthma prescribing based on the Arg16Gly ADRB2 genotype versus current treatment based on no genetic testing. Using four state-transition models, we estimate cost and QALYs employing micro-simulation modeling with a time horizon of 10 years and a cycle length of 1 week. Cost-effectiveness was assessed at a willingness-to-pay (WTP) value of US$5180. RESULTS: The mean incremental cost of strategy genetic testing versus no genetic testing is US$ -6809. The mean incremental benefit of strategy genetic testing is 16 QALYs. The incremental net monetary benefit of strategic genetic testing versus no genetic testing is US$ 88,893. Genetic testing is the strategy with the highest expected net benefit. The outcomes derived from our primary analysis remained robust when subjected to variations in all underlying assumptions and parameter values. CONCLUSION: Genetic testing of Arg16Gly ADRB2 is a cost-effective strategy to address asthma management in asthmatic children requiring ICS+LABA. This result should encourage the generation of more evidence and the incorporation of such evidence into clinical practice guidelines for pediatric asthma.

5.
BMC Infect Dis ; 24(1): 98, 2024 Jan 18.
Article in English | MEDLINE | ID: mdl-38238670

ABSTRACT

INTRODUCTION: Ventilator-associated pneumonia (VAP) is a prominent cause of morbidity and mortality in intensive care unit (ICU) patients. Due to the increase in Methicillin resistant Staphylococcus aureus infection, it is important to consider other more effective and safer alternatives compared to vancomycin. This motivates evaluating whether the use of an apparently more expensive drug such as linezolid can be cost-effective in Colombia. METHODS: A decision tree was used to simulate the results in terms of the cost and proportion of cured patients. In the simulation, patients can receive antibiotic treatment with linezolid (LZD 600 mg IV/12 h) or vancomycin (VCM 15 mg/kg iv/12 h) for 7 days, patients they can experience events adverse (renal failure and thrombocytopenia). The model was analyzed probabilistically, and a value of information analysis was conducted to inform the value of conducting further research to reduce current uncertainties in the evidence base. Cost-effectiveness was evaluated at a willingness-to-pay (WTP) value of US$5180. RESULTS: The mean incremental cost of LZD versus VCM is US$-517. This suggests that LZD is less costly. The proportion of patients cured when treated with LZD compared with VCM is 53 vs. 43%, respectively. The mean incremental benefit of LZD versus VCM is 10 This position of absolute dominance (LZD has lower costs and higher proportion of clinical cure than no supplementation) is unnecessary to estimate the incremental cost-effectiveness ratio. There is uncertainty with a 0.999 probability that LZD is more cost-effective than VCM. Our base-case results were robust to variations in all assumptions and parameters. CONCLUSION: LNZ is a cost-effective strategy for patients, ≥ 18 years of age, with VAP in Colombia- Our study provides evidence that can be used by decision-makers to improve clinical practice guidelines.


Subject(s)
Cross Infection , Methicillin-Resistant Staphylococcus aureus , Pneumonia, Staphylococcal , Pneumonia, Ventilator-Associated , Humans , Linezolid/therapeutic use , Linezolid/pharmacology , Vancomycin/therapeutic use , Cost-Benefit Analysis , Pneumonia, Ventilator-Associated/drug therapy , Colombia , Cross Infection/drug therapy , Anti-Bacterial Agents/pharmacology
7.
J Asthma ; 61(4): 292-299, 2024 Apr.
Article in English | MEDLINE | ID: mdl-37815886

ABSTRACT

BACKGROUND: Omalizumab is a humanized monoclonal antibody that specifically binds to free human immunoglobulin E. The introduction of this drug raises concerns about economic impact in scenarios with constrained. This study aimed to estimate the cost utility of omalizumab in adults with severe asthma uncontrolled in Colombia. METHODS: We used a Markov state-transition model to estimate the cost and QALYs associated with omalizumab compared to standard of care; from a third payer perspective over a lifetime horizon. This model used local costs while utilities were derived from international literature. Cost and transition probabilities were obtained from a mixture of Colombian-specific and internationally published data. RESULTS: The mean incremental cost of omalizumab versus standard of care is US$3 481. The mean incremental benefit of omalizumab versus standard of care 0.094 QALY. The incremental expected cost per unit of benefit is estimated at US$36846 per QALY. There is only a probability of 0.032 that Omalizumab is more cost-effective than standard of care at a threshold of US$5180 per QALY. CONCLUSION: Omalizumab is not cost-effective in adults with severe asthma uncontrolled in Colombia. If the cost of Omalizumab is reduced by 83%, this treatment would be cost-effective in our country. Our study provides evidence that should be used by decision-makers to improve clinical practice guidelines and should be replicated to validate their results in other middle-income countries.


Subject(s)
Anti-Asthmatic Agents , Asthma , Adult , Humans , Omalizumab/therapeutic use , Asthma/therapy , Colombia , Anti-Asthmatic Agents/therapeutic use , Cost-Effectiveness Analysis , Cost-Benefit Analysis , Quality-Adjusted Life Years
8.
J Asthma ; : 1-6, 2023 Dec 25.
Article in English | MEDLINE | ID: mdl-38145333

ABSTRACT

BACKGROUND: Tailoring asthma interventions based on biomarkers could substantially impact the high cost associated with asthma morbidity. For policymakers, the main concern is the economic impact of adopting this technology, especially in developing countries. This study evaluates the budget impact of asthma management using sputum eosinophil counts in Colombia patients between 4 and 18 years of age. METHODS: A budget impact analysis was performed to evaluate the potential financial impact of sputum eosinophil counts (EO). The study considered a 5-year time horizon and the Colombian National Health System perspective. The incremental budget impact was calculated by subtracting the cost of the new treatment, in which EO is reimbursed, from the cost of the conventional therapy without EO (management based on clinical symptoms (with or without spirometry/peak flow) or asthma guidelines (or both), for asthma-related). Univariate one-way sensitivity analyses were performed. RESULTS: In the base-case analysis, the 5-year costs associated with EO and no-EO were estimated to be US$ 532.865.915 and US$ 540.765.560, respectively, indicating savings for Colombian National Health equal to US$ 7.899.645, if EO is adopted for the routine management of patients with persistent asthma. This result was robust in univariate sensitivity one-way analysis. CONCLUSION: EO was cost-saving in guiding the treatment of patients between 4 and 18 years of age with persistent asthma. Decision-makers in our country can use this evidence to improve clinical practice guidelines, and it should be replicated to validate their results in other middle-income countries.

9.
Brain Sci ; 13(6)2023 May 23.
Article in English | MEDLINE | ID: mdl-37371322

ABSTRACT

In recent years, the endoscopic endonasal approach (EEA) for craniopharyngiomas has proven to be a safe option for extensive tumor resection, with minimal or no manipulation of the optic nerves and excellent visualization of the superior hypophyseal branches when compared to the Transcranial Approach (TCA). However, there is an ongoing debate regarding the criteria for selecting different approaches. To explore the current results of EEA and discuss its role in the management of craniopharyngiomas, we performed MEDLINE, Embase, and LILACS searches from 2012 to 2022. Baseline characteristics, the extent of resection, and clinical outcomes were evaluated. Statistical analysis was performed through an X2 and Fisher exact test, and a comparison between quantitative variables through a Kruskal-Wallis and verified with post hoc Bonferroni. The tumor volume was similar in both groups (EEA 11.92 cm3, -TCA 13.23 cm3). The mean follow-up in months was 39.9 for EEA and 43.94 for TCA, p = 0.76). The EEA group presented a higher visual improvement rate (41.96% vs. 25% for TCA, p < 0.0001, OR 7.7). Permanent DI was less frequent with EEA (29.20% vs. 67.40% for TCA, p < 0.0001, OR 0.2). CSF Leaks occurred more frequently with EEA (9.94% vs. 0.70% for TCA, p < 0.0001, OR 15.8). Recurrence rates were lower in the EEA group (EEA 15.50% vs. for TCA 21.20%, p = 0.04, OR 0.7). Our results demonstrate that, in selected cases, EEA for resection of craniopharyngiomas is associated with better results regarding visual preservation and extent of tumor resection. Postoperative CSF leak rates associated with EEA have improved compared to the historical series. The decision-making process should consider each person's characteristics; however, it is noticeable that recent data regarding EEA justify its widespread application as a first-line approach in centers of excellence for skull base surgery.

10.
Biomedica ; 43(1): 37-43, 2023 03 30.
Article in English, Spanish | MEDLINE | ID: mdl-37167467

ABSTRACT

Nocardiosis is a disease with worldwide distribution. It is usually found in tropical areas and mainly affects immunocompromised patients, however, there are also cases where its infection has been reported in immunocompetent patients. This pathology is caused by bacteria known as Nocardia spp., which are gram-positive microorganisms and environmental saprophytes, and although exposure to Nocardia spp. is almost universal, only a small fraction of exposed people develops the disease. We present the case of a 47-year-old man, with no evidence of immunosuppression, from a rural area of Boyacá, who was admitted due to intense and intermittent headache accompanied by paresthesia and, finally, a decrease in consciousness. A brain magnetic resonance was performed and evidenced a fronto-temporo- occipital space-occupying lesion in the cortico-subcortical region with a compressive effect and displacement of the ventricular system cavities. It was suspected at first a neoplastic lesion or a brain abscess. The lesion was surgically resected, and its culture showed Nocardia africana/nova. In later studies a possible primary pulmonary focus was evidenced. Alcoholism was the only risk factor documented. The patient completed 6 weeks of hospital antibiotic treatment with favorable clinical and radiological evolution and was discharged with a 1-year plan of outpatient antibiotic therapy. Although Nocardia spp. mainly affects immunocompromised patients, evidence shows that this microorganism can also be a threat to individuals without traditional immunosuppression risk factors.


La nocardiosis es una enfermedad de distribución mundial; de forma habitual se encuentra en zonas tropicales y afecta principalmente a pacientes inmunocomprometidos, sin embargo, también existen casos reportados de infección en personas inmunocompetentes. Esta infección es causada por actinomicetos del género Nocardia spp. que son bacterias Gram positivas, saprófitos ambientales. Aunque la exposición a Nocardia spp. es casi universal, solo una pequeña fracción de las personas expuestas desarrollan la enfermedad. Se presenta el caso de un hombre de 47 años, sin dato de inmunosupresión, procedente de un área rural de Boyacá, que consultó por un cuadro clínico de cefalea intensa e intermitente, con parestesias y, finalmente, alteración del estado de conciencia. Se practicó una resonancia magnética cerebral, en la que se evidenció una lesión que ocupaba espacio de localización córtico-subcortical en la región fronto-témporo-parietal izquierda, con efecto compresivo y desplazamiento de las cavidades del sistema ventricular. Se sospechó, inicialmente, una lesión neoplásica o un absceso cerebral. El paciente fue sometido a una resección quirúrgica, y el cultivo de la lesión documentó Nocardia africana/nova; en estudios posteriores, se evidenció un posible foco pulmonar primario. Como único factor de riesgo en el paciente, se documentó alcoholismo. Completó seis semanas de tratamiento antibiótico intrahospitalario con evolución clínica y radiológica, y egresó con plan de un año de terapia antibiótica ambulatoria. Aunque la enfermedad por Nocardia spp. afecta principalmente a pacientes inmunocomprometidos, la "evidencia" clínica demuestra que este microorganismo también puede ser una amenaza para individuos sin los factores de riesgo tradicionales para inmunosupresión.


Subject(s)
Nocardia Infections , Nocardia , Humans , Retrospective Studies
11.
Biomédica (Bogotá) ; 43(1): 37-43, mar. 2023. tab, graf
Article in Spanish | LILACS | ID: biblio-1533916

ABSTRACT

La nocardiosis es una enfermedad de distribución mundial; de forma habitual se encuentra en zonas tropicales y afecta principalmente a pacientes inmunocomprometidos, sin embargo, también existen casos reportados de infección en personas inmunocompetentes. Esta infección es causada por actinomicetos del género Nocardia spp. que son bacterias Gram positivas, saprófitos ambientales. Aunque la exposición a Nocardia spp. es casi universal, solo una pequeña fracción de las personas expuestas desarrollan la enfermedad. Se presenta el caso de un hombre de 47 años, sin dato de inmunosupresión, procedente de un área rural de Boyacá, que consultó por un cuadro clínico de cefalea intensa e intermitente, con parestesias y, finalmente, alteración del estado de conciencia. Se practicó una resonancia magnética cerebral, en la que se evidenció una lesión que ocupaba espacio de localización córtico-subcortical en la región fronto-témporo-parietal izquierda, con efecto compresivo y desplazamiento de las cavidades del sistema ventricular. Se sospechó, inicialmente, una lesión neoplásica o un absceso cerebral. El paciente fue sometido a una resección quirúrgica, y el cultivo de la lesión documentó Nocardia africana/nova; en estudios posteriores, se evidenció un posible foco pulmonar primario. Como único factor de riesgo en el paciente, se documentó alcoholismo. Completó seis semanas de tratamiento antibiótico intrahospitalario con evolución clínica y radiológica, y egresó con plan de un año de terapia antibiótica ambulatoria. Aunque la enfermedad por Nocardia spp. afecta principalmente a pacientes inmunocomprometidos, la "evidencia" clínica demuestra que este microorganismo también puede ser una amenaza para individuos sin los factores de riesgo tradicionales para inmunosupresión.


Nocardiosis is a disease with worldwide distribution. It is usually found in tropical areas and mainly affects immunocompromised patients, however, there are also cases where its infection has been reported in immunocompetent patients. This pathology is caused by bacteria known as Nocardia spp., which are gram-positive microorganisms and environmental saprophytes, and although exposure to Nocardia spp. is almost universal, only a small fraction of exposed people develops the disease. We present the case of a 47-year-old man, with no evidence of immunosuppression, from a rural area of Boyacá, who was admitted due to intense and intermittent headache accompanied by paresthesia and, finally, a decrease in consciousness. A brain magnetic resonance was performed and evidenced a fronto-temporo- occipital space-occupying lesion in the cortico-subcortical region with a compressive effect and displacement of the ventricular system cavities. It was suspected at first a neoplastic lesion or a brain abscess. The lesion was surgically resected, and its culture showed Nocardia africana/nova. In later studies a possible primary pulmonary focus was evidenced. Alcoholism was the only risk factor documented. The patient completed 6 weeks of hospital antibiotic treatment with favorable clinical and radiological evolution and was discharged with a 1-year plan of outpatient antibiotic therapy. Although Nocardia spp. mainly affects immunocompromised patients, evidence shows that this microorganism can also be a threat to individuals without traditional immunosuppression risk factors.


Subject(s)
Nocardia Infections , Brain Abscess , Immunocompromised Host , Alcoholism , Immunocompetence , Nocardia
12.
Rev. colomb. gastroenterol ; 36(3): 499-503, jul.-set. 2021. graf
Article in English, Spanish | LILACS | ID: biblio-1347360

ABSTRACT

Resumen El reparo de la hernia hiatal es un tema de debate debido a las posibles complicaciones asociadas que han cambiado a través de los años. En la literatura se reportan complicaciones asociadas al procedimiento hasta en un 30 % de los casos. Las complicaciones diferentes a la recurrencia y a largo plazo son infrecuentes, reportadas en menos del 9 % de los casos. La inclusión de la malla protésica en el esófago es una rara complicación y solo se han reportado pocos casos sobre esta. Entre los factores asociados a este desenlace se encuentran descritos: el material protésico, la técnica quirúrgica y la tensión de la malla sobre el tejido intervenido; sin embargo, es difícil establecer asociaciones directas de cada factor dado que la literatura actual solo cuenta con reportes de casos. A continuación, se muestra el caso clínico de un paciente, quien, después de una reparación de hernia hiatal con malla, presenta la inclusión de material protésico en el esófago; se aborda el diagnóstico y el manejo de la misma.


Abstract Hiatal hernia repair has been a subject of debate due to the possible associated complications that have changed over the years. The literature reports up to 30% of cases with complications associated with the procedure. Complications other than recurrence and long-term complications are rare and reported in less than 9% of cases. The migration of the prosthetic mesh into the esophagus is a rare complication and only a few cases have been reported. The factors associated with this outcome include prosthetic material, surgical technique, and mesh tension on the intervened tissue. However, it is difficult to establish direct associations of each factor since the current literature has only case reports. The following is a clinical case of a patient in whom the prosthetic material migrated into the esophagus after a hiatal hernia repair with mesh. The diagnosis and treatment offered are discussed.


Subject(s)
Humans , Male , Aged, 80 and over , Surgical Mesh , Esophagogastric Junction , Hernia, Hiatal , Patients , Diagnosis
13.
BMC Res Notes ; 12(1): 584, 2019 Sep 18.
Article in English | MEDLINE | ID: mdl-31533801

ABSTRACT

OBJECTIVE: The aim of this study was to compare in vivo effect of five pharmacological options on inflammation and pulmonary fibrosis induced by paraquat. METHODS: 54 Wistar SPF rats were used. After 2 h post-intoxication with paraquat ion, groups of 9 animals were randomly assigned to (1) cyclophosphamide plus dexamethasone (2) low molecular weight heparin (3) unfractionated heparin (4) vitamin C every 24 h, (5) atorvastatin or (6) placebo with intraperitoneal saline. Lung inflammation, alveolar injury, hepatocyte damage, hepatic regeneration, acute tubular necrosis and kidney congestion were evaluated. RESULTS: In the control group 100% of animals presented moderate and severe lung inflammation, while in the groups with atorvastatin and intratracheal heparin this proportion was lower (55.5%; CI 26.6-81.3%) (p = 0.025). A lower degree of moderate or severe hepatic regeneration was evident in the treatment groups with atorvastatin (p = 0.009). In this study was demonstrated that statins and heparin might have a protective effect in the paraquat-induced destructive phase. More evidence is needed to evaluated of dose-response effects of these drugs before to study in clinical trials.


Subject(s)
Drug Therapy/methods , Lung/drug effects , Pneumonia/drug therapy , Pulmonary Alveoli/drug effects , Pulmonary Fibrosis/drug therapy , Animals , Antioxidants/pharmacology , Ascorbic Acid/pharmacology , Atorvastatin/pharmacology , Cyclophosphamide/pharmacology , Dexamethasone/pharmacology , Drug Therapy, Combination , Heparin/pharmacology , Heparin, Low-Molecular-Weight/pharmacology , Lung/pathology , Paraquat/toxicity , Pneumonia/pathology , Pulmonary Alveoli/pathology , Pulmonary Fibrosis/chemically induced , Rats, Wistar , Treatment Outcome
14.
Rev Bras Ter Intensiva ; 29(2): 253-258, 2017.
Article in Portuguese, English | MEDLINE | ID: mdl-28977266

ABSTRACT

This study aimed to explore the usefulness of measuring respiratory muscle activity in mechanically ventilated patients suffering from acute organophosphate poisoning, with a view towards providing complementary information to determine the best time to suspend ventilatory support. Surface electromyography in respiratory muscles (diaphragm, external intercostal and sternocleidomastoid muscles) was recorded in a young man affected by self-poisoning with an unknown amount of parathion to determine the muscle activity level during several weaning attempts from mechanical ventilation. The energy distribution of each surface electromyography signal frequency, the synchronization between machine and patient and between muscles, acetylcholinesterase enzyme activity, and work of breathing and rapid shallow breathing indices were calculated in each weaning attempt. The work of breathing and rapid shallow breathing indices were not correlated with the failure/success of the weaning attempt. The diaphragm gradually increased its engagement with ventilation, achieving a maximal response that correlated with successful weaning and maximal acetylcholinesterase enzyme activity; in contrast, the activity of accessory respiratory muscles showed an opposite trend.


Este estudo teve como objetivo explorar a utilidade da avaliação da atividade muscular respiratória em pacientes em uso de ventilação mecânica após envenenamento agudo por organofosforados, para fornecer informações complementares para determinação do melhor momento para suspensão do suporte ventilatório. Foi registrada eletromiografia de superfície em músculos respiratórios (diafragma, intercostais externos e esternocleidomastóideos) em um homem jovem afetado por autoenvenenamento com quantidade desconhecida de paration, para determinar o nível de atividade muscular no decurso de diversas tentativas de desmame da ventilação mecânica. A distribuição de energia de cada frequência de sinal de eletromiografia de superfície; a sincronização entre máquina, paciente e músculos; a atividade da enzima acetilcolinesterase; o trabalho respiratório e os índices de respiração rápida e superficial foram calculados em cada uma das tentativas de desmame. O trabalho respiratório e o índice de respiração rápida e superficial não se correlacionaram com a falha ou o sucesso da tentativa de desmame. O diafragma aumentou gradualmente seu envolvimento com a ventilação, tendo alcançado resposta máxima, que se correlacionou com o sucesso do desmame e a atividade máxima da enzima acetilcolinesterase. Por outro lado, a atividade de músculos respiratórios acessórios mostrou tendência oposta.


Subject(s)
Electromyography/methods , Organophosphate Poisoning/therapy , Respiration, Artificial/methods , Ventilator Weaning , Acetylcholinesterase/metabolism , Adult , Humans , Male , Respiration , Respiratory Muscles/physiology
15.
Rev. bras. ter. intensiva ; 29(2): 253-258, abr.-jun. 2017. tab, graf
Article in Portuguese | LILACS | ID: biblio-899506

ABSTRACT

RESUMO Este estudo teve como objetivo explorar a utilidade da avaliação da atividade muscular respiratória em pacientes em uso de ventilação mecânica após envenenamento agudo por organofosforados, para fornecer informações complementares para determinação do melhor momento para suspensão do suporte ventilatório. Foi registrada eletromiografia de superfície em músculos respiratórios (diafragma, intercostais externos e esternocleidomastóideos) em um homem jovem afetado por autoenvenenamento com quantidade desconhecida de paration, para determinar o nível de atividade muscular no decurso de diversas tentativas de desmame da ventilação mecânica. A distribuição de energia de cada frequência de sinal de eletromiografia de superfície; a sincronização entre máquina, paciente e músculos; a atividade da enzima acetilcolinesterase; o trabalho respiratório e os índices de respiração rápida e superficial foram calculados em cada uma das tentativas de desmame. O trabalho respiratório e o índice de respiração rápida e superficial não se correlacionaram com a falha ou o sucesso da tentativa de desmame. O diafragma aumentou gradualmente seu envolvimento com a ventilação, tendo alcançado resposta máxima, que se correlacionou com o sucesso do desmame e a atividade máxima da enzima acetilcolinesterase. Por outro lado, a atividade de músculos respiratórios acessórios mostrou tendência oposta.


ABSTRACT This study aimed to explore the usefulness of measuring respiratory muscle activity in mechanically ventilated patients suffering from acute organophosphate poisoning, with a view towards providing complementary information to determine the best time to suspend ventilatory support. Surface electromyography in respiratory muscles (diaphragm, external intercostal and sternocleidomastoid muscles) was recorded in a young man affected by self-poisoning with an unknown amount of parathion to determine the muscle activity level during several weaning attempts from mechanical ventilation. The energy distribution of each surface electromyography signal frequency, the synchronization between machine and patient and between muscles, acetylcholinesterase enzyme activity, and work of breathing and rapid shallow breathing indices were calculated in each weaning attempt. The work of breathing and rapid shallow breathing indices were not correlated with the failure/success of the weaning attempt. The diaphragm gradually increased its engagement with ventilation, achieving a maximal response that correlated with successful weaning and maximal acetylcholinesterase enzyme activity; in contrast, the activity of accessory respiratory muscles showed an opposite trend.


Subject(s)
Humans , Male , Adult , Respiration, Artificial/methods , Ventilator Weaning , Electromyography/methods , Organophosphate Poisoning/therapy , Acetylcholinesterase/metabolism , Respiration , Respiratory Muscles/physiology
16.
Rev. colomb. cir ; 32(3): 182-185, 20170000.
Article in Spanish | LILACS, COLNAL | ID: biblio-905167

ABSTRACT

La coledocolitiasis es una enfermedad frecuente, presente en 10 a 18 % de los pacientes con colelitiasis. Su tratamiento usual actualmente consiste en practicar primero una colangiopancreatografía retrógrada endoscópica (CPRE) y luego la colecistectomía; si la primera es fallida, está indicada la exploración de la vía biliar con colocación de tubo en T o cierre primario. El abordaje laparoscópico es el estándar a nivel mundial; sin embargo, no es una práctica común en nuestro medio. Se presenta una serie de 12 pacientes con diagnóstico de colecisto-coledocolitiasis y con CPRE previa fallida, que fueron sometidos a colecistectomía y exploración de vía biliar con cierre primario por laparoscopia, entre mayo de 2015 y mayo de 2016. Su evolución mostró buenos resultados: en 10 de ellos la estancia hospitalaria fue de menos de 5 días después del procedimiento quirúrgico. Se concluye que la colecistectomía y la exploración de la vía biliar con cierre primario por laparoscopia es una técnica segura, con tiempos cortos de estancia hospitalaria


Choledocolithiasis is a frequent pathology, it is present in about 10-18% of the patients with cholelithiasis. Endoscopic retrograde cholangiopancreatography (ERCP) with subsequent cholecystectomy is the routine established procedure for this pathology. If it fails, the routine is to proceed with a common bile duct exploration with the insertion of a T tube or primary closure. Laparoscopic surgery is the worldwide standardized procedure; however, it is not a common practice in our environment. In this report, we evaluated 12 patients with cholecysto-choledocholithiasis with previously failed ERCP that underwent laparoscopic cholecystectomy and common bile duct exploration with primary closure in the period May 2015 - May 2016. Our patients had good postoperatory course with appropriate outcomes; 83% had less than 5 days of hospital stay following surgery. It was concluded that performing laparoscopic cholecystectomy and common bile duct exploration with primary closure is a safe technique with low hospital stay after surgery


Subject(s)
Humans , Cholecystectomy, Laparoscopic , Choledocholithiasis , Common Bile Duct , Suture Techniques
17.
Value Health Reg Issues ; 2(3): 357-360, 2013 Dec.
Article in English | MEDLINE | ID: mdl-29702770

ABSTRACT

OBJECTIVE: To describe the frequency of adverse drugs events (ADEs) as possible causes of request of drugs not included in national essential Medicines list in Colombia. METHODS: This was a descriptive study developed in a private medical insurance company in Bogota, Colombia. Data were obtained from drug request form of drugs not included in a national essential Medicines list. We analyzed the content of the notes to identify the records related to the occurrence of ADEs in the period 2008 to 2009. Information concerning the adverse event and the drug involved was recorded in a data collection instrument developed by the researchers. The pharmacological classification of drugs was performed according to the Anatomical Therapeutic Chemical Classification System (ATC). RESULTS: We study 3,336 request forms of drugs not included in a national essential Medicines list. The level 1 groups of the ATC of drugs with greater frequency of ADEs were the cardiovascular agents (47%), nervous system agents (24%) and antineoplastic and immunomodulating agents (15%). The great majority was cases of light severity (62.7%) and classified as possible (48.4%). CONCLUSION: The results of this study support the innovative approach of using request form of drug not included in national essential Medicines list to obtain information regarding ADEs in developing countries; recognizing the importance of looking for new sources of report of adverse reactions to diminish the under-notification of ADEs.

18.
Article in English | MEDLINE | ID: mdl-22255388

ABSTRACT

Accurate quantification of loss of response to external stimuli is essential for understanding the mechanisms of loss of consciousness under general anesthesia. We present a new approach for quantifying three possible outcomes that are encountered in behavioral experiments during general anesthesia: correct responses, incorrect responses and no response. We use a state-space model with two state variables representing a probability of response and a conditional probability of correct response. We show applications of this approach to an example of responses to auditory stimuli at varying levels of propofol anesthesia ranging from light sedation to deep anesthesia in human subjects. The posterior probability densities of model parameters and the response probability are computed within a Bayesian framework using Markov Chain Monte Carlo methods.


Subject(s)
Anesthesia, General , Bayes Theorem , Behavior , Humans , Reference Values
19.
Article in English | MEDLINE | ID: mdl-22255393

ABSTRACT

Coherence analysis characterizes frequency-dependent covariance between signals, and is useful for multivariate oscillatory data often encountered in neuroscience. The global coherence provides a summary of coherent behavior in high-dimensional multivariate data by quantifying the concentration of variance in the first mode of an eigenvalue decomposition of the cross-spectral matrix. Practical application of this useful method is sensitive to noise, and can confound coherent activity in disparate neural populations or spatial locations that have a similar frequency structure. In this paper we describe two methodological enhancements to the global coherence procedure that increase robustness of the technique to noise, and that allow characterization of how power within specific coherent modes change through time.


Subject(s)
Anesthesia, General , Electroencephalography/methods , Multivariate Analysis , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...